Dohn LH, Jensen BV, Larsen FO. Short time infusion of bevacizumab in combination with 5FU-based chemotherapy as first-line therapy in a non-selective patient group with metastatic colorectal cancer. AO [Internet]. 2010 Jan. 1 [cited 2026 Apr. 26];49(3):395-6. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/32595